NE

Naveenkumar Embadi

Director Additional Director DIN 06625427
DIN 06625427 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Naveenkumar Embadi

Data last updated:

Naveenkumar Embadi was an Additional Director at Confero Healthcare Private Limited (2013–2017) and Director at Aalok Life Sciences Private Limited (from 2014). The companies operate in Pharma.

DIN 06625427
Primary Designation Additional Director
Industry Pharma
First Appointment 14 Jun 2013
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Confero Healthcare Private Limited U24232TG2011PTC075131
Additional Director14 Jun 20132011₹11.9 Lakh (FY 2017)Strike Off
Aalok Life Sciences Private Limited U24100TG2014PTC092512
Director27 Jan 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aalok Life Sciences Private Limited
Confero Healthcare Private Limited
Premium access

Shareholding and investment profile for Naveenkumar Embadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveenkumar Embadi

Naveenkumar Embadi was first appointed on 14 Jun 2013 as Additional Director at Confero Healthcare Private Limited. The most recent appointment on record is 27 Jan 2014 at Aalok Life Sciences Private Limited.

Naveenkumar Embadi held 2 earlier board appointments: Confero Healthcare Private Limited (Additional Director, 14 Jun 2013 to 25 May 2017); Aalok Life Sciences Private Limited (Director, from 27 Jan 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available